Loading...
Loading...
Teva Pharmaceutical Industries Ltd.
TEVA announced today that it has
entered into a new five-year, $3.0 billion unsecured revolving credit
facility, which replaces its existing $2.5 billion credit facility.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
We simplify the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in